Preferred Label : adverse effects;

CISMeF synonym : Adverse Drug Reaction;

MeSH synonym : injurious effects; side effects; undesirable effects;

Details


Main resources

You can consult :


https://www.has-sante.fr/jcms/c_2058872/fr/iqss-2020-ete-ortho-evenements-thrombo-emboliques-apres-pose-de-prothese-totale-de-hanche-hors-fracture-ou-de-genou
2026
false
false
false
France
arthroplasty, replacement, knee
arthroplasty, replacement, hip
quality indicators, health care
patient safety
deep vein thrombosis
pulmonary embolism
technical report
thromboembolism

---
https://ansm.sante.fr/actualites/enceinte-les-medicaments-cest-toujours-pas-nimporte-comment
2024
false
false
false
France
French
drug information
pregnancy
pregnant women
pharmaceutical preparations
abnormalities, drug-induced

---
https://sfsep.org/sep-et-vaccinations/
2024
true
false
false
false
France
guidelines as topic
professional practice
patient care management
drug interactions
Immunosuppression Therapy
guideline
multiple sclerosis
multiple sclerosis
multiple sclerosis, nos
vaccination, nos
preventive immunization/medication
vaccination
Multiple sclerosis
multiple sclerosis

---
https://ansm.sante.fr/tableau-marr/tafamidis
2024
false
false
false
France
French
risk management
tafamidis
administration, oral
guidelines for drug use
tafamidis
adult
pregnancy
breast feeding
tafamidis
Cardiac Amyloidosis
amyloidosis, hereditary, Transthyretin-Related
amyloidosis, hereditary, Transthyretin-Related

---
Ezetrol (ezetimibe) and the Risks of Drug-Induced Liver Injury and Severe Cutaneous Adverse Reactions
https://recalls-rappels.canada.ca/fr/avis-rappel/ezetrol-ezetimibe-et-risques-lesions-hepatiques-origine-medicamenteuse-et-reactions
2024
false
false
false
Canada
French
English
pharmacovigilance note
Ezetimibe
Chemical and Drug Induced Liver Injury
Drug-Induced Liver Disease
drug hypersensitivity syndrome
stevens-johnson syndrome
epidermal necrolysis, toxic
Drug-Induced stevens johnson syndrome
canada
administration, oral
ezetimibe
anticholesteremic agents

---
https://ansm.sante.fr/tableau-marr/sutimlimab
2024
false
false
false
France
French
risk management
sutimlimab
guidelines for drug use
sutimlimab
antibodies, monoclonal, humanized
infusions, intravenous
Infections
Infections
meningococcal vaccines
meningococcal infections
vaccination
serious infection
patient education handout

---
https://ansm.sante.fr/actualites/progestatifs-et-risque-de-meningiomes-intracraniens-le-bmj-publie-une-etude-epidemiologique-francaise
2024
false
false
false
France
French
pharmacovigilance note
epidemiologic studies
france
meningioma
meningioma
medroxyprogesterone acetate
risk assessment
Product containing only levonorgestrel in intrauterine dose form (medicinal product form)
levonorgestrel
injections, intramuscular
plastic iud with progestogen
administration, intravaginal
progestins
intrauterine devices
medroxyprogesterone

---
https://www.cbip.be/fr/articles/4284?folia=4275
2024
false
false
false
Belgium
French
Dutch
journal article
pseudoephedrine
belgium
europe

---
https://ansm.sante.fr/informations-de-securite/en-cas-de-rhume-ne-pas-utiliser-de-medicaments-a-base-de-pseudoephedrine-vasoconstricteurs-par-voie-orale
2024
false
false
false
France
French
pseudoephedrine
administration, oral
pharmacovigilance note
nasal decongestants
common cold
risk factors
risk
pseudoephedrine
pseudoephedrine, combinations
guidelines

---
https://ansm.sante.fr/tableau-marr/ritlecitinib
2024
false
false
false
France
French
risk management
Ritlecitinib
Drug-Related side effects and adverse reactions
ritlecitinib
guidelines for drug use
patient education handout
administration, oral
Janus Kinase Inhibitors
Immunomodulating Agents

---
https://ansm.sante.fr/tableau-marr/dronedarone
2024
false
false
false
France
French
risk management
continuity of patient care
Dronedarone
Dronedarone
dronedarone
administration, oral
guidelines for drug use
patient education handout
atrial fibrillation
Persistent Atrial Fibrillation
Paroxysmal Atrial Fibrillation
anti-arrhythmia agents
anti-arrhythmia agents

---
https://ansm.sante.fr/tableau-marr/crizotinib
2024
false
false
false
France
French
patients guideline
patient education handout
drug information
risk management
Crizotinib
Crizotinib
continuity of patient care
crizotinib
vision disorders
adult
child

---
https://ansm.sante.fr/tableau-marr/inotersen
2024
false
false
false
France
French
risk management
Inotersen
inotersen
Drug-Related side effects and adverse reactions
patients guideline
drug information
eye diseases
glomerulonephritis
thrombocytopenia
oligonucleotides
oligodeoxyribonucleotides, antisense

---
https://ansm.sante.fr/tableau-marr/etanercept-1
2024
false
false
false
France
French
risk management
Etanercept
patients guideline
drug information
Drug-Related side effects and adverse reactions

---
https://ansm.sante.fr/actualites/en-cas-de-rhume-evitez-les-medicaments-vasoconstricteurs-par-voie-orale
2024
false
false
false
France
French
common cold
administration, oral
nasal decongestants
pseudoephedrine
pharmacovigilance note
patients guideline
nasopharyngitis
pseudoephedrine, combinations
myocardial infarction
stroke
Posterior reversible encephalopathy syndrome (disorder)
Reversible cerebral vasoconstriction syndrome (disorder)

---
https://ansm.sante.fr/tableau-marr/pirfenidone
2024
false
false
false
France
French
guidelines for drug use
risk management
pirfenidone
pirfenidone
administration, oral
patient education handout
photosensitization
Drug-induced photosensitivity (disorder)
pirfenidone
Chemical and Drug Induced Liver Injury
continuity of patient care
liver function tests
Drug-Related side effects and adverse reactions

---
https://ansm.sante.fr/tableau-marr/eculizumab-2
2024
false
false
false
France
French
risk management
eculizumab
eculizumab
eculizumab
guidelines for drug use
patient education handout
patients guideline
antibiotic prophylaxis
infusions, intravenous
Infections
sepsis
Drug-Related side effects and adverse reactions
meningococcal infections
vaccination
meningococcal vaccines

---
https://ansm.sante.fr/tableau-marr/elranatamab
2024
false
false
false
France
French
risk management
Elranatamab
drug information
patients guideline
Cytokine Release Syndrome
nervous system diseases

---
https://ansm.sante.fr/informations-de-securite/adagrasib-risque-potentiel-deffets-indesirables-cutanes-severes
2024
false
false
false
France
French
pharmacovigilance note
risk
adagrasib
stevens-johnson syndrome
epidermal necrolysis, toxic
adagrasib
antineoplastic agents
Adagrasib Regimen

---
https://ansm.sante.fr/tableau-marr/ranibizumab-2
2024
false
false
false
France
French
Ranibizumab
byooviz
drug information
patient education handout
risk management
Drug-Related side effects and adverse reactions
signs and symptoms
ranibizumab
intravitreal injections

---
https://ansm.sante.fr/actualites/nouvelles-donnees-en-faveur-dun-risque-accru-de-saignements-menstruels-abondants-apres-la-primovaccination-contre-le-covid-19
2024
false
false
false
France
French
pharmacovigilance note
COVID-19 Vaccines
vaccination
COVID-19
mRNA Vaccines
Administration of first dose of vaccine product containing only severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (procedure)
technical report
menorrhagia
covid-19, RNA-based vaccine
risk
risk assessment

---
https://ansm.sante.fr/actualites/retour-dinformation-sur-le-prac-de-janvier-2024-8-11-janvier
2024
false
false
false
France
French
risk management
valproic acid
Male
Neurodevelopmental Disorders
Chimeric antigen receptor T-cell therapy
genetic therapy
Secondary Carcinoma
Chimeric Antigen Receptor Therapy
immunotherapy, adoptive
pharmacovigilance note

---
https://ansm.sante.fr/tableau-marr/mecasermine
2024
false
false
false
France
French
risk management
mecasermin
mecasermin
mecasermin
Drug-Related side effects and adverse reactions
patient education handout
guidelines for drug use
mecasermin
hypoglycemia
injections, subcutaneous

---
https://ansm.sante.fr/informations-de-securite/pseudoephedrine-risques-de-syndrome-dencephalopathie-posterieure-reversible-pres-et-de-syndrome-de-vasoconstriction-cerebrale-reversible-rcvs
2024
false
false
false
France
French
pharmacovigilance note
pseudoephedrine
Posterior reversible encephalopathy syndrome (disorder)
posterior leukoencephalopathy syndrome
Reversible cerebral vasoconstriction syndrome (disorder)
cerebrovascular disorders
pseudoephedrine
administration, oral
nasal decongestants
pseudoephedrine, combinations

---
https://ansm.sante.fr/tableau-marr/aciclovir
2024
false
false
false
France
French
guideline
patients guideline
drug information
risk management
acyclovir
Accidental Drug Ingestion
Muco-adhesive Buccal Tablet Dosage Form

---
https://www.cbip.be/fr/articles/4263?folia=4259
2024
false
false
false
Belgium
French
journal article
drug information
glucocorticoids
administration, oral
Long-term current use of drug therapy (situation)

---
https://ansm.sante.fr/actualites/retour-dinformation-sur-le-prac-de-fevrier-2024-5-8-fevrier
2024
false
false
false
France
French
pharmacovigilance note
nirmatrelvir and ritonavir drug combination
nirmatrelvir and ritonavir drug combination
immunosuppressive agents
drug therapy, combination
drug interactions

---
https://ansm.sante.fr/tableau-marr/leflunomide
2024
false
false
false
France
French
risk management
patients guideline
guidelines for drug use
Leflunomide
leflunomide
administration, oral
immunosuppressive agents
continuity of patient care
Drug-Related side effects and adverse reactions

---
https://ansm.sante.fr/tableau-marr/tetradecyl-sulfate-de-sodium
2024
false
false
false
France
French
risk management
guidelines for drug use
continuity of patient care
sodium tetradecyl sulfate
sclerosing solutions
sodium tetradecyl sulfate
sodium tetradecyl sulfate
injections, intravenous
sclerotherapy

---
https://ansm.sante.fr/tableau-marr/dabigatran
2024
false
false
false
France
French
guidelines for drug use
risk management
Dabigatran
Dabigatran
dabigatran etexilate
administration, oral
antithrombins
antithrombins
continuity of patient care
hemorrhage
risk
adult
child

---
https://ansm.sante.fr/tableau-marr/venetoclax
2024
false
false
false
France
French
risk management
venetoclax
venetoclax
patient education handout
tumor lysis syndrome
administration, oral
antineoplastic agents

---
https://ansm.sante.fr/tableau-marr/cladribine
2024
false
false
false
France
French
risk management
cladribine
administration, oral
cladribine
immunosuppressive agents
cladribine
guidelines for drug use
patients guideline
Drug-Related side effects and adverse reactions
adult
multiple sclerosis, relapsing-remitting
continuity of patient care
hematologic tests

---
https://ansm.sante.fr/tableau-marr/inebilizumab
2024
false
false
false
France
French
risk management
inebilizumab
inebilizumab
infusions, intravenous
patients guideline
product surveillance, postmarketing
patient safety
adult
neuromyelitis optica
Immunosuppression-related infectious disease (disorder)
leukoencephalopathy, progressive multifocal
virus diseases
serious infection

---
https://ansm.sante.fr/tableau-marr/ranibizumab
2024
false
false
false
France
French
risk management
Ranibizumab
Ranibizumab
patients guideline
intravitreal injections
patient education handout
package leaflet
ranibizumab

---
https://ansm.sante.fr/tableau-marr/tolvaptan
2024
false
false
false
France
French
risk management
Tolvaptan
Tolvaptan
administration, oral
tolvaptan
polycystic kidney, autosomal dominant
continuity of patient care
liver diseases
pregnancy
guidelines for drug use
patients guideline
patient education handout

---
https://ansm.sante.fr/tableau-marr/olanzapine
2024
false
false
false
France
French
guidelines for drug use
patient education handout
Olanzapine
risk management
olanzapine
injections, intramuscular
Delayed-Action preparations
Olanzapine
metabolic diseases
continuity of patient care
drug compounding
injections, intramuscular
olanzapine pamoate
olanzapine pamoate
schizophrenia
antipsychotic agents
antipsychotic agents
medication errors
Post-injection delirium sedation syndrome (finding)

---
https://ansm.sante.fr/tableau-marr/lenalidomide
2024
false
false
false
France
French
risk management
pregnancy
contraception
lenalidomide
multiple myeloma
lymphoma, mantle-cell
teratogens
continuity of patient care
drug monitoring
clinical chemistry tests
myelodysplastic syndromes
guidelines for drug use
popular works
venous thromboembolism
Tumor Flare Reaction
neoplasms
Chemical and Drug Induced Liver Injury
angiogenesis inhibitors
angiogenesis inhibitors
thalidomide
thalidomide
thalidomide
Lenalidomide
Lenalidomide

---
https://ansm.sante.fr/tableau-marr/pomalidomide
2024
false
false
false
France
French
risk management
pregnancy
contraception
teratogens
abnormalities, drug-induced
multiple myeloma
pomalidomide
continuity of patient care
Drug-Related side effects and adverse reactions
risk factors
guidelines for drug use
thrombocytopenia
neutropenia
blood cell count
thromboembolism
Infections
patient education handout
pregnancy tests
forms
thalidomide
thalidomide

---
https://ansm.sante.fr/tableau-marr/thalidomide
2024
false
false
false
France
French
risk management
thalidomide
teratogens
abnormalities, drug-induced
pregnancy
thalidomide
guideline
forms
patient education handout
continuity of patient care
Neuropathy peripheral
thromboembolism
Drug-Related side effects and adverse reactions
pregnancy tests
contraception
package leaflet

---
https://ansm.sante.fr/tableau-marr/tocilizumab-1
2024
false
false
false
France
French
risk management
tocilizumab
infusions, intravenous
injections, subcutaneous
guidelines for drug use
tocilizumab
tocilizumab
patient education handout
continuity of patient care
tocilizumab

---
https://ansm.sante.fr/actualites/risque-de-meningiome-et-progestatifs-recommandations-generales-pour-limiter-ce-risque
2023
false
false
false
France
French
guidelines for drug use
meningioma
progestins
Drug-Related side effects and adverse reactions
risk management
administration, oral
meningioma

---
https://ansm.sante.fr/tableau-marr/idecabtagene-vicleucel
2023
false
false
false
France
French
guidelines for drug use
popular works
risk management
idecabtagene vicleucel
idecabtagene vicleucel
Drug-Related side effects and adverse reactions
Drug-Related side effects and adverse reactions
Cytokine Release Syndrome
drug compounding
idecabtagene vicleucel
gene therapy
immunotherapy, adoptive
idecabtagene vicleucel
continuity of patient care
nervous system diseases
infusions, intravenous
Antineoplastic Agents, Immunological
Antineoplastic Agents, Immunological
multiple myeloma
Cytokine Release Syndrome
Cytokine Release Syndrome
signs and symptoms

---
https://ansm.sante.fr/tableau-marr/ranibizumab-1
2023
false
false
false
France
French
risk management
patient education handout
Ranibizumab
Drug-Related side effects and adverse reactions
signs and symptoms
ranibizumab
Product containing precisely ranibizumab 10 milligram/1 milliliter conventional release solution for injection (clinical drug)
intravitreal injections

---
https://www.cbip.be/fr/articles/4045?folia=4031
2023
false
false
false
Belgium
French
journal article
proton pump inhibitors

---
https://ansm.sante.fr/tableau-marr/upadacitinib
2023
false
false
false
France
French
risk management
upadacitinib
patient education handout
guidelines for drug use
upadacitinib
Drug-Related side effects and adverse reactions
administration, oral
upadacitinib
Janus Kinase Inhibitors
Janus Kinase Inhibitors
teratogens
pregnancy
continuity of patient care
herpes zoster
tuberculosis
neoplasms
embolism and thrombosis
Virus Reactivation

---
https://ansm.sante.fr/tableau-marr/tofacitinib
2023
false
false
false
France
French
risk management
tofacitinib
tofacitinib
continuity of patient care
checklist
guidelines for drug use
patient education handout
Janus Kinase Inhibitors
tofacitinib
Drug-Related side effects and adverse reactions
Janus Kinase Inhibitors
pregnancy
teratogens
Virus Reactivation
tuberculosis
neoplasms
embolism and thrombosis
herpes zoster

---
https://ansm.sante.fr/actualites/epi-phare-publie-dans-le-nejm-les-resultats-dune-etude-qui-montre-quil-ny-a-pas-daugmentation-du-risque-devenement-cardiovasculaire-grave-avec-les-vaccins-bivalents-contre-le-covid-19
2023
false
false
false
France
French
drug information
COVID-19 Vaccines
Bivalent Vaccines
mRNA Vaccines
cardiovascular diseases

---
PUBLIÉ LE 31/03/2023
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-le-covid-19-periode-du-10-02-2023-au-16-03-2023
2023
false
false
false
France
French
mRNA Vaccine
mRNA Vaccines
NVX-CoV2373 adjuvated lipid nanoparticle
drug information
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
Drug-Related side effects and adverse reactions
drug monitoring
Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 antigen (procedure)
Covid-19 vaccines
COVID-19
COVID-19 Vaccines

---
https://ansm.sante.fr/tableau-marr/baricitinib
2023
false
false
false
France
French
risk management
guidelines for drug use
patient education handout
baricitinib
baricitinib
continuity of patient care
Janus Kinase Inhibitors
Drug-Related side effects and adverse reactions
Janus Kinase Inhibitors
baricitinib

---
https://ansm.sante.fr/actualites/comment-limiter-la-survenue-des-effets-indesirables-des-collyres-mydriatiques-chez-les-enfants
2023
false
false
false
France
French
guidelines for drug use
patient education handout
mydriatics
ophthalmic solutions
child

---
https://ansm.sante.fr/actualites/les-enfants-exposes-a-lhydroxychloroquine-pendant-la-grossesse-de-leur-mere-courent-un-risque-plus-eleve-de-malformation-grave-a-la-naissance
2023
false
false
false
France
French
abnormalities, drug-induced
teratogens
pharmacovigilance note
pregnancy
hydroxychloroquine
risk
patient education handout
In Utero Drug Exposure
antirheumatic agents

---
https://ansm.sante.fr/informations-de-securite/inhibiteurs-de-janus-kinase-et-traitement-des-maladies-inflammatoires-chroniques-restrictions-dutilisation-pour-diminuer-le-risque-deffets-indesirables-graves
https://ansm.sante.fr/actualites/inhibiteurs-de-janus-kinase-et-traitement-des-maladies-inflammatoires-chroniques-restrictions-dutilisation-pour-diminuer-le-risque-deffets-indesirables-graves
2023
false
false
false
France
French
pharmacovigilance note
guidelines for drug use
Janus Kinase Inhibitors
Chronic inflammatory disorder (disorder)
chronic disease

---
https://publications.msss.gouv.qc.ca/msss/document-003568/
2023
false
false
false
Canada
noise
guideline
noise

---
https://ansm.sante.fr/dossiers-thematiques/acne-severe-et-traitement-par-isotretinoine
2023
false
false
false
France
French
video recording
popular works
isotretinoin
administration, oral
isotretinoin
pregnancy
isotretinoin
teratogens
acne vulgaris

---
https://www.cbip.be/fr/articles/4070?folia=4050
2023
false
false
false
Belgium
French
anticonvulsants
teratogens
pregnancy
journal article

---
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-le-covid-19-periode-du-16-03-2023-au-13-04-2023
2023
false
false
false
France
French
mRNA Vaccine
mRNA Vaccines
NVX-CoV2373 adjuvated lipid nanoparticle
summary of product characteristics
package leaflet
drug information
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
Drug-Related side effects and adverse reactions
drug monitoring
Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 antigen (procedure)
Covid-19 vaccines
COVID-19
COVID-19 Vaccines

---
https://ansm.sante.fr/tableau-marr/ravulizumab
2023
false
false
false
France
French
risk management
ravulizumab
ravulizumab
ravulizumab
infusions, intravenous
guidelines for drug use
patients guideline
continuity of patient care
meningococcal infections
sepsis
neisseria meningitidis
vaccination
antibiotic prophylaxis
meningococcal infections
sepsis
child
infant
hemoglobinuria, paroxysmal
Atypical Hemolytic Uremic Syndrome
myasthenia gravis, generalized

---
https://www.cbip.be/fr/articles/4075?folia=4050
2023
false
false
false
Belgium
French
journal article
administration, oral
ivermectin
ivermectin
antiparasitic agents
drug eruptions
epidermal necrolysis, toxic
stevens-johnson syndrome
pharmacovigilance note

---
https://ansm.sante.fr/tableau-marr/faricimab
2023
false
false
false
France
French
risk management
faricimab
risk
patient education handout
faricimab
intravitreal injections
Drug-Related side effects and adverse reactions
signs and symptoms
wet macular degeneration
diabetic retinopathy
Macular edema due to diabetes mellitus (disorder)
patients guideline
sound

---
https://www.cbip.be/fr/articles/4090?folia=4079
2023
false
false
false
Belgium
French
lactation disorders
journal article
pharmaceutical preparations
Drug-Related side effects and adverse reactions
breast feeding

---
https://ansm.sante.fr/actualites/evaluation-europeenne-du-risque-potentiel-de-troubles-neurodeveloppementaux-chez-les-enfants-dont-le-pere-a-ete-traite-par-valproate-dans-les-mois-precedant-la-conception
2023
false
false
false
France
French
Neurodevelopmental Disorders
valproate
fathers
paternal exposure
valproic acid
risk assessment
comparative study
drug information
valproic acid
anticonvulsants
europe
Neurodevelopmental Disorders
child

---
https://www.cbip.be/fr/articles/4084?folia=4079
2023
false
false
false
Belgium
French
journal article
sodium
pharmaceutic aids
cardiovascular diseases

---
https://ansm.sante.fr/tableau-marr/filgotinib
2023
false
false
false
France
French
guidelines for drug use
risk management
filgotinib
administration, oral
patient education handout
filgotinib
filgotinib
Janus Kinase Inhibitors
adult
aged
pregnancy
breast feeding
Janus Kinase Inhibitors
arthritis, rheumatoid

---
https://ansm.sante.fr/tableau-marr/methoxyflurane
2023
false
false
false
France
French
risk management
methoxyflurane
administration, inhalation
guidelines for drug use
methoxyflurane
methoxyflurane
Drug-Related side effects and adverse reactions
emergency treatment
pain
wounds and injuries
Post-traumatic pain

---
https://ansm.sante.fr/tableau-marr/axicabtagene-ciloleucel
2023
false
false
false
France
French
risk management
axicabtagene ciloleucel
guidelines for drug use
axicabtagene ciloleucel
Drug-Related side effects and adverse reactions
Cytokine Release Syndrome
nervous system diseases
patient education handout
signs and symptoms
axicabtagene ciloleucel
infusions, intravenous
gene therapy

---
https://ansm.sante.fr/tableau-marr/brexucabtagene-autoleucel
2023
false
false
false
France
French
risk management
brexucabtagene autoleucel
genetic therapy
gene therapy
Cytokine Release Syndrome
signs and symptoms
guidelines for drug use
patient education handout
Drug-Related side effects and adverse reactions
nervous system diseases
brexucabtagene autoleucel
brexucabtagene autoleucel

---
https://ansm.sante.fr/tableau-acces-derogatoire/oxbryta-voxelotor
2023
false
false
false
France
French
risk management
voxelotor
voxelotor
administration, oral
hematologic agents
drug information
anemia, hemolytic
anemia, sickle cell

---
https://ansm.sante.fr/tableau-marr/abrocitinib
2023
false
false
false
France
French
risk management
abrocitinib
abrocitinib
administration, oral
Drug-Related side effects and adverse reactions
guidelines for drug use
patient education handout

---
https://ansm.sante.fr/actualites/risque-dallergie-grave-aux-curares-en-cas-dutilisation-des-sirops-contre-la-toux-contenant-de-la-pholcodine
2023
false
false
false
France
French
pharmacovigilance note
antitussive agents
pholcodine
drug hypersensitivity
Safety-Based drug withdrawals
cross reactions
neuromuscular blocking agents
pholcodine
pholcodine

---
https://ansm.sante.fr/tableau-marr/brolucizumab
2023
false
false
false
France
French
risk management
brolucizumab
intravitreal injections
patients guideline
drug information

---
https://ansm.sante.fr/tableau-marr/citrate-de-cafeine
2023
false
false
false
France
French
pharmacovigilance note
caffeine citrate
guidelines for drug use
infant, newborn
infusions, intravenous
infant, premature
caffeine citrate
sleep apnea, newborn, primary
Primary apnea in the newborn (finding)
sleep apnea, central
caffeine
citrates
caffeine
citrates

---
https://ansm.sante.fr/tableau-marr/chlorhydrate-de-mexiletine
2023
false
false
false
France
French
pharmacovigilance note
mexiletine hydrochloride
guidelines for drug use
risk management
mexiletine hydrochloride
arrhythmias, cardiac
hepatic insufficiency
mexiletine hydrochloride
patient education handout
Drug-Related side effects and adverse reactions
risk
continuity of patient care
mexiletine
mexiletine
mexiletine

---
https://ansm.sante.fr/tableau-marr/fenfluramine
2023
false
false
false
France
French
administration, oral
risk management
guidelines for drug use
pharmacovigilance note
fenfluramine
fenfluramine
continuity of patient care
drug monitoring
hypertension, pulmonary
Drug-Related side effects and adverse reactions
heart valve diseases
patient education handout

---
https://ansm.sante.fr/tableau-marr/esketamine
2023
false
false
false
France
French
guidelines for drug use
patients guideline
patient education handout
Esketamine
ketamine
dissociative disorders
administration, intranasal
antidepressive agents
risk management
esketamine
Esketamine
antidepressive agents
continuity of patient care
dissociation
Sleepiness
hypertension
Drug Misuse
ketamine

---
https://ansm.sante.fr/tableau-marr/fingolimod
2023
false
false
false
France
French
guidelines for drug use
patient education handout
Fingolimod Hydrochloride
pregnancy
administration, oral
immunosuppressive agents
immunosuppressive agents
fingolimod
continuity of patient care
Fingolimod Hydrochloride
teratogens
multiple sclerosis, relapsing-remitting
breast feeding
Fingolimod Hydrochloride
risk management

---
https://ansm.sante.fr/tableau-marr/eculizumab
2023
false
false
false
France
French
risk management
guidelines for drug use
eculizumab
eculizumab
continuity of patient care
drug monitoring
patient safety
sepsis
meningococcal infections
risk
vaccination
antibiotic prophylaxis
adult
child
infant
patients guideline
patient education handout

---
https://ansm.sante.fr/tableau-marr/baclofene
2023
false
false
false
France
French
baclofen
baclofen
risk management
guidelines for drug use
patients guideline
patient education handout
continuity of patient care
drug monitoring
alcoholism

---
https://ansm.sante.fr/tableau-marr/propranolol
2023
false
false
false
France
French
risk management
propranolol
propranolol hydrochloride
administration, oral
guidelines for drug use
patients guideline
child
Drug-Related side effects and adverse reactions
bronchial spasm
hypoglycemia
convulsive seizures
adrenergic beta-antagonists
hemangioma, capillary
propranolol

---
https://www.medsubhyp.fr/recommandations-en-sante-au-travail/
2023
false
false
false
France
French
consensus
adolescent
adult
pregnancy
hematologic diseases
cardiovascular diseases
respiratory tract diseases
eye diseases
skin diseases
tooth diseases
kidney diseases
gastrointestinal diseases
musculoskeletal diseases
otorhinolaryngologic diseases
occupational medicine
occupational medicine
occupational health physicians
return to work
government regulation
signs and symptoms
aged
hearing tests
respiratory function tests
risk assessment
accidents
barotrauma
barotrauma
occupational exposure
central nervous system diseases
occupational medicine
submarine medicine
mental disorders
work capacity evaluation

---
https://ansm.sante.fr/tableau-marr/teriflunomide
2023
false
false
false
France
French
administration, oral
risk reduction
patients guideline
handbooks
pregnancy
teratogens
teriflunomide
risk management
contraception
Contraindications, Drug
breast feeding
Chemical and Drug Induced Liver Injury
continuity of patient care
multiple sclerosis, relapsing-remitting
leukopenia
hypertension
opportunistic infections
teriflunomide
crotonates
toluidines
crotonates
toluidines

---
https://ansm.sante.fr/tableau-marr/alemtuzumab
2023
false
false
false
France
French
risk management
Alemtuzumab
Alemtuzumab
alemtuzumab
infusions, intravenous
continuity of patient care
multiple sclerosis, relapsing-remitting
guidelines for drug use
patients guideline
patient education as topic
Drug-Related side effects and adverse reactions
drug monitoring
clinical chemistry tests
thyroid diseases
purpura, thrombocytopenic, idiopathic
kidney diseases
anti-glomerular basement membrane disease
Infections
pregnancy
mass screening
Contraindications, Drug
premedication

---
https://ansm.sante.fr/tableau-marr/alitretinoine
2023
false
false
false
France
French
guidelines for drug use
patients guideline
forms
administration, oral
teratogens
pregnancy
contraception
alitretinoin
mental disorders
dyslipidemias
continuity of patient care
pancreatitis
transaminases
Chemical and Drug Induced Liver Injury
drug monitoring
risk management
clinical chemistry tests
patient education handout
tretinoin
tretinoin
Alitretinoin
Alitretinoin

---
https://ansm.sante.fr/tableau-marr/emicizumab
2023
false
false
false
France
French
emicizumab
risk management
thromboembolism
hemorrhage
thrombotic microangiopathies
blood coagulation tests
risk
hemorrhage
hemophilia A
patients guideline
guidelines for drug use
handbooks
Drug-Related side effects and adverse reactions
injections, subcutaneous
emicizumab
antibodies, bispecific
antibodies, monoclonal, humanized

---
https://ansm.sante.fr/tableau-marr/levonorgestrel-diu
2023
false
false
false
France
French
administration, intravaginal
levonorgestrel
risk management
patient education handout
intrauterine devices, medicated
plastic iud with progestogen
pregnancy, ectopic
risk
guideline
Insertion of intrauterine contraceptive device (procedure)
Contraceptive Effectiveness

---
https://ansm.sante.fr/tableau-marr/lutecium-177lu-oxodotreotide
2023
false
false
false
France
French
lutetium Lu 177 dotatate
risk management
patients guideline
lutetium Lu 177 dotatate
infusions, intravenous
radiotherapy
radiopharmaceuticals
radiopharmaceuticals
neuroendocrine tumors
lutetium (177Lu) oxodotreotide
drug information
organometallic compounds
octreotide
octreotide
organometallic compounds
octreotide

---
https://ansm.sante.fr/tableau-marr/rituximab
2023
false
false
false
France
French
risk management
Rituximab
Rituximab
infusions, intravenous
injections, subcutaneous
rituximab
guidelines for drug use
risk
leukoencephalopathy, progressive multifocal
Infections
Drug-Related side effects and adverse reactions
continuity of patient care
drug monitoring
patient education handout
drug compounding

---
https://ansm.sante.fr/tableau-marr/rituximab-1
2023
false
false
false
France
French
Rituximab
Rituximab
risk management
infusions, intravenous
rituximab
medication errors
guidelines for drug use
patient education handout
risk
leukoencephalopathy, progressive multifocal
Infections
Drug-Related side effects and adverse reactions
continuity of patient care
drug monitoring

---
https://ansm.sante.fr/tableau-marr/rituximab-2
2023
false
false
false
France
French
Rituximab
Rituximab
risk management
Drug-Related side effects and adverse reactions
patient education handout
guidelines for drug use
infusions, intravenous
rituximab
leukoencephalopathy, progressive multifocal
Infections
medication errors
continuity of patient care

---
https://ansm.sante.fr/tableau-marr/valproate-et-derives
2023
false
false
false
France
French
risk management
valproate
pregnancy
teratogens
valproate sodium
-
Divalproex Sodium
dipropylacetamide
pregnancy tests
contraception
guideline
patient education handout
forms
developmental disabilities
Contraindications, Drug
valproic acid
valproic acid

---
https://www.ansm.sante.fr/actualites/anti-inflammatoires-non-steroidiens-ains-et-complications-infectieuses-graves
2023
false
false
false
France
French
pharmacovigilance note
anti-inflammatory agents, non-steroidal
Infections
fever
pain
ibuprofen
ketoprofen
adult
child
streptococcal infections
guidelines for drug use

---
https://ansm.sante.fr/actualites/acidose-lactique-et-metformine-un-risque-evitable
2023
false
false
false
France
French
risk management
metformin
acidosis, lactic
Drug-Related side effects and adverse reactions
acidosis, lactic
pharmacovigilance note
guidelines for drug use
patients guideline
renal insufficiency
risk factors
continuity of patient care
hypoglycemic agents
Renal function monitoring (regime/therapy)

---
PUBLIÉ LE 17/05/2023
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-le-covid-19-periode-du-13-04-2023-au-11-05-2023
2023
false
false
false
France
French
mRNA Vaccine
mRNA Vaccines
NVX-CoV2373 adjuvated lipid nanoparticle
summary of product characteristics
package leaflet
drug information
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
Drug-Related side effects and adverse reactions
drug monitoring
Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 antigen (procedure)
Covid-19 vaccines
COVID-19
COVID-19 Vaccines

---
https://www.cbip.be/fr/articles/4098?folia=4095
2023
false
false
false
Belgium
French
journal article
Immunosuppression Therapy
immunosuppressive agents
neoplasms
graft rejection
organ transplantation
risk
risk assessment
neoplasms

---
https://ansm.sante.fr/informations-de-securite/gavreto-pralsetinib-augmentation-du-risque-de-tuberculose-et-mesures-de-reduction-du-risque-associees
2023
false
false
false
France
French
pharmacovigilance note
risk
tuberculosis
pralsetinib
pralsetinib

---
http://www.lecrat.eu/?s=Canakinumab+-+Grossesse+et+allaitement
2023
false
false
false
France
French
drug information
pregnancy
breast feeding
canakinumab

---
https://www.has-sante.fr/jcms/p_3445860/fr/flash-securite-patient-les-soins-en-ville-les-risques-existent-aussi
2023
false
false
false
France
therapeutics
guideline
urban health services

---
https://www.infectiologie.com/fr/actualites/position-de-la-spilf-sur-les-effets-indesirables-des-fluoroquinolones_-n.html
2023
false
false
false
France
scientific and technical information
fluoroquinolones

---
https://ansm.sante.fr/actualites/progestatifs-et-meningiome-pas-daugmentation-du-risque-avec-les-diu-au-levonorgestrel-mais-confirmation-du-risque-pour-3-nouvelles-substances
2023
false
false
false
France
French
technical report
pharmacovigilance note
meningioma
risk assessment
meningioma
intrauterine devices, medicated
levonorgestrel
progestins
promegestone
medrogestone
administration, oral
medroxyprogesterone acetate
injections, intramuscular
administration, intravaginal
retrospective studies

---
https://ansm.sante.fr/informations-de-securite/clomid-50-mg-comprime-risque-de-troubles-visuels-graves-cecite
2023
false
false
false
France
French
blindness
pharmacovigilance note
risk
clomiphene
vision disorders
clomiphene citrate
clomifene
optic neuritis
optic neuropathy, ischemic
retinal vein occlusion
Central Retinal Vein Occlusion
retinal detachment
vitreous detachment

---
https://ansm.sante.fr/actualites/clomid-citrate-de-clomifene-le-traitement-doit-etre-arrete-en-cas-dalteration-de-la-vision
2023
false
false
false
France
French
guidelines for drug use
clomiphene
vision disorders
pharmacovigilance note
clomiphene citrate
fertility agents, female
clomifene

---
https://ansm.sante.fr/actualites/lamotrigine-attention-au-risque-deruption-cutanee-grave-en-particulier-au-debut-du-traitement
2023
false
false
false
France
French
pharmacovigilance note
Lamotrigine
lamotrigine
drug eruptions
administration, oral
anticonvulsants
antipsychotic agents
drug hypersensitivity syndrome
epidermal necrolysis, toxic
Drug-Induced stevens johnson syndrome
guidelines for drug use

---
https://www.anses.fr/fr/content/complements-alimentaires-plantes-meilleure-information-des-consommateurs
2023
false
false
false
France
French
phytotherapy
herb-drug interactions
plants, medicinal
scientific and technical information
drug information
guidelines
plants, medicinal
dietary supplements

---
https://ansm.sante.fr/actualites/traitement-de-lacne-severe-mieux-faire-connaitre-les-risques-associes-a-lisotretinoine-orale
2023
false
false
false
France
French
isotretinoin
administration, oral
acne vulgaris
teratogens
pregnancy
mental disorders
drug information
isotretinoin
video recording

---
https://ansm.sante.fr/tableau-marr/anakinra
2023
false
false
false
France
French
risk management
anakinra
guidelines for drug use
patient education handout

---
https://ansm.sante.fr/informations-de-securite/valproate-et-derives-risque-potentiel-de-troubles-neurodeveloppementaux-chez-les-enfants-dont-le-pere-a-ete-traite-dans-les-3-mois-qui-precedent-la-conception
2023
false
false
false
France
French
pharmacovigilance note
Divalproex Sodium
Neurodevelopmental Disorders
Male
risk
risk assessment
fathers
infant
child
Perinatal Exposure
paternal exposure
valproic acid
valproate sodium
teratogens

---
https://ansm.sante.fr/informations-de-securite/antibiotiques-de-la-famille-des-fluoroquinolones-administres-par-voie-systemique-ou-inhalee-rappel-des-restrictions-dutilisation
2023
false
false
false
France
French
guidelines for drug use
pharmacovigilance note
fluoroquinolones
administration, oral
administration, inhalation
injections
Off-Label use

---
https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medeffet-canada/infovigilance-produits-sante/juillet-2023.html#a3.1.1
2023
false
false
false
Canada
French
English
COVID-19 Vaccines
mRNA Vaccines
menorrhagia
vaccination
canada
drug information

---
https://ansm.sante.fr/informations-de-securite/ketamine-une-utilisation-prolongee-entraine-des-atteintes-graves-hepatiques-et-uronephrologiques
2023
false
false
false
France
French
pharmacovigilance note
ketamine
kidney diseases
Drug-Induced Liver Disease
cystitis
narcotics
prescription drug misuse
guidelines for drug use
Long-Term
Off-Label use
biliary tract diseases

---
https://ansm.sante.fr/actualites/lansm-rappelle-le-bon-usage-de-la-ketamine
2023
false
false
false
France
French
ketamine
ketamine
guidelines for drug use
analgesics
analgesics
analgesics
ketamine
pain, intractable
chronic pain
biliary tract diseases
kidney diseases
urologic diseases
Drug-Induced Liver Disease
continuity of patient care
patient education handout
Off-Label use
prescription drug misuse
narcotics

---
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-le-covid-19-periode-du-14-04-2023-au-8-06-2023
2023
false
false
false
France
French
mRNA Vaccine
mRNA Vaccines
NVX-CoV2373 adjuvated lipid nanoparticle
drug information
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
Drug-Related side effects and adverse reactions
drug monitoring
Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 antigen (procedure)
Covid-19 vaccines
COVID-19
COVID-19 Vaccines

---
Domperidone and psychiatric withdrawal events when used off-label for lactation stimulation
https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medeffet-canada/infovigilance-produits-sante/aout-2023.html#a3-1-1
2023
false
false
false
Canada
French
English
pharmacovigilance note
domperidone
Off-Label use
substance withdrawal syndrome
Lactation stimulation therapy

---
Wearable Respiratory Sensor for the Detection of Opioid-Induced Respiratory Depression
https://www.cadth.ca/fr/un-capteur-portable-pour-detecter-la-depression-respiratoire-causee-par-un-opioide
2023
false
false
false
Canada
French
English
health technology assessment
respiratory depression
opioids
Wearable Electronic Devices

---
https://ansm.sante.fr/tableau-marr/patisiran
2023
false
false
false
France
French
risk management
patisiran
patisiran
guidelines for drug use
patisiran
infusions, intravenous
Drug-Related side effects and adverse reactions
patient education handout
Adverse reaction caused by drug or medicament administered by infusion (disorder)
Infusion Site Reaction
Infusion Site Reaction
signs and symptoms

---
https://ansm.sante.fr/actualites/deodorant-nuud-retrait-du-marche-par-le-fabricant-de-lensemble-des-lots-de-ce-deodorant
2023
false
false
false
France
French
deodorants
vigilance note
epidermal cyst
epidermal cyst
superinfection

---
https://ansm.sante.fr/dossiers-thematiques/campagne-de-vaccination-au-college
2023
false
false
false
France
French
mass vaccination
vaccination
schools
guideline
papillomavirus vaccines
drug surveillance, postmarketing
continuity of patient care
adverse drug reaction reporting systems
Drug-Related side effects and adverse reactions

---
https://www.has-sante.fr/jcms/p_3459828/fr/chlormadinone-viatris-acetate-de-chlormadinone-gynecologie
2023
false
false
false
France
chlormadinone acetate
treatment outcome
insurance, health, reimbursement
risk assessment
chlormadinone
meningioma
premenopause
progesterone
hormone replacement therapy
menstruation disturbances
mastodynia
endometriosis
evaluation of the transparency committee
chlormadinone acetate

---
https://www.has-sante.fr/jcms/p_3459822/fr/lutenyl-acetate-de-nomegestrol-gynecologie
2023
false
false
false
France
nomegestrol acetate
risk assessment
treatment outcome
meningioma
nomegestrol
premenopause
hormone replacement therapy
menstruation disturbances
menopause
progesterone
evaluation of the transparency committee
nomegestrol acetate

---
https://ansm.sante.fr/actualites/topiramate-epitomax-et-generiques-et-troubles-neurodeveloppementaux-mise-en-place-de-mesures-en-europe-pour-limiter-lutilisation-pendant-la-grossesse
2023
false
false
false
France
French
pharmacovigilance note
guidelines for drug use
Topiramate
pregnancy
europe
Neurodevelopmental Disorders
risk
risk management
drug evaluation
Topiramate
france
anticonvulsants
anticonvulsants
anticonvulsants
Topiramate
topiramate
Female of Childbearing Potential

---
https://www.cbip.be/fr/articles/4164?folia=4158
2023
false
false
false
Belgium
French
journal article
risk
pregnancy
benzodiazepines
hypnotics and sedatives
patient safety
Z-drugs

---
https://ansm.sante.fr/informations-de-securite/lamotrigine-lamictal-et-generiques-rappel-du-bon-usage-afin-de-limiter-le-risque-deruption-cutanee-grave-en-particulier-au-debut-du-traitement
2023
false
false
false
France
French
pharmacovigilance note
guidelines for drug use
Lamotrigine
Lamotrigine
risk management
lamotrigine
anticonvulsants
anticonvulsants
stevens-johnson syndrome
drug eruptions
Drug-Related side effects and adverse reactions
epidermal necrolysis, toxic
drug hypersensitivity syndrome
adult
child
drug interactions

---
https://ansm.sante.fr/informations-de-securite/medicaments-a-base-de-mianserine-rappel-du-bon-usage-et-des-risques-deffets-indesirables-graves-notamment-chez-les-patients-ages
2023
false
false
false
France
French
mianserin
aged
risk
mianserin
pharmacovigilance note
guidelines for drug use
Off-Label use
sleep initiation and maintenance disorders
depressive disorder, major
antidepressive agents, second-generation

---
https://ansm.sante.fr/tableau-marr/glofitamab
2023
false
false
false
France
French
guidelines for drug use
risk management
antibodies, bispecific
antibodies, bispecific
glofitamab
glofitamab
patients guideline
Tumor Flare Reaction
signs and symptoms
continuity of patient care
Cytokine Release Syndrome
glofitamab

---
https://ansm.sante.fr/tableau-marr/lisocabtagene-maraleucel
2023
false
false
false
France
French
guidelines for drug use
risk management
Lisocabtagene Maraleucel
Lisocabtagene Maraleucel
Product containing only lisocabtagene maraleucel in parenteral dose form (medicinal product form)
Cytokine Release Syndrome
continuity of patient care
gene therapy
immunotherapy, adoptive
signs and symptoms
nervous system diseases
patients guideline
lisocabtagene maraleucel

---
https://ansm.sante.fr/actualites/campagne-de-vaccination-contre-les-virus-hpv-lansm-deploie-un-dispositif-de-surveillance-renforcee
2023
false
false
false
France
French
drug information
mass vaccination
papillomavirus vaccines
france
papillomavirus infections
pharmacovigilance
product surveillance, postmarketing
papillomavirus vaccines

---
https://www.cbip.be/fr/articles/4168?folia=4158
2023
false
false
false
Belgium
French
pharmacovigilance note
journal article
clomiphene
selective estrogen receptor modulators
vision disorders
Clomiphene adverse reaction (disorder)
clomiphene

---
Summary Safety Review - Keytruda (pembrolizumab) and Tecentriq (atezolizumab) - Assessing the Potential Risk of Aplastic Anemia
https://pmps.hpfb-dgpsa.ca/documents-d-examen/ressource/SSR1691503886633
2023
false
false
false
Canada
French
drug evaluation
Drug-Related side effects and adverse reactions
pembrolizumab
antibodies, monoclonal, humanized
atezolizumab
Antineoplastic Agents, Immunological
risk assessment
anemia, aplastic
Immune Checkpoint Inhibitors
canada
pharmacovigilance note

---
https://ansm.sante.fr/tableau-marr/eculizumab-1
2023
false
false
false
France
French
risk management
guidelines for drug use
eculizumab
eculizumab
continuity of patient care
Drug-Related side effects and adverse reactions
vaccination
patients guideline
Infections
sepsis
meningococcal infections

---
https://ansm.sante.fr/tableau-marr/lomitapide
2023
false
false
false
France
French
risk management
lomitapide
lomitapide
patient education handout
guideline
drug interactions
anticholesteremic agents
lomitapide
anticholesteremic agents
administration, oral

---
http://www.lecrat.eu/1778/
2023
false
false
false
France
French
drug information
valproic acid
paternal exposure
Neurodevelopmental Disorders
child
infant

---
https://ansm.sante.fr/actualites/les-vaccins-a-arnm-naugmentent-pas-le-risque-de-syndrome-de-guillain-barre-a-la-difference-des-vaccins-a-vecteur-adenoviral
2023
false
false
false
France
French
risk assessment
mRNA Vaccines
guillain-barre syndrome
drug evaluation
product surveillance, postmarketing
evaluation studies as topic
covid-19, RNA-based vaccine
COVID-19 Vaccines
COVID-19

---
https://ansm.sante.fr/actualites/encore-trop-de-grossesses-sous-carbamazepine-nous-souhaitons-renforcer-linformation-pour-limiter-lexposition
2023
false
false
false
France
French
pharmacovigilance note
pregnancy
carbamazepine
teratogens
abnormalities, drug-induced
guidelines for drug use

---
https://ansm.sante.fr/tableau-marr/epcoritamab
2023
false
false
false
France
French
risk management
bispecific monoclonal antibodies
Epcoritamab
patients guideline
Cytokine Release Syndrome
signs and symptoms
Immune Effector Cell Associated Neurotoxicity Syndrome
cell-associated neurotoxicity
drug information
epcoritamab

---
https://ansm.sante.fr/actualites/retour-dinformation-sur-le-prac-doctobre-2023-25-28-septembre
2023
false
false
false
France
French
pharmacovigilance note
product surveillance, postmarketing
Omacor
omega-3-triglycerides incl. other esters and acids
atrial fibrillation
omega-3 ethyl ester 90

---
https://ansm.sante.fr/actualites/retour-dinformation-sur-le-prac-de-novembre-2023-23-26-octobre
2023
false
false
false
France
French
drug information
risk assessment
thyroid neoplasms
glucagon-like peptide 1
hypoglycemic agents
GLP-1 Mimetics
Glucagon-like peptide-1 (GLP-1) analogues

---
https://www.cbip.be/fr/articles/4188?folia=4179
2023
false
false
false
Belgium
French
journal article
pharmacovigilance note
migraine disorders
Drug-Related side effects and adverse reactions
alopecia
Medicinal product acting as antimigraine agent (product)
Calcitonin gene-related peptide (CGRP) antagonists
calcitonin gene-related peptide
Calcitonin Gene-Related Peptide Receptor Antagonists

---
https://ansm.sante.fr/informations-de-securite/esters-ethyliques-dacides-omega-3-risque-accru-et-dose-dependant-de-fibrillation-auriculaire-ou-atriale-chez-des-patients-atteints-de-maladies-cardiovasculaires-ou-presentant-des-facteurs-de-risque-cardiovasculaires
2023
false
false
false
France
French
pharmacovigilance note
risk
Dose-dependent
atrial fibrillation
risk factors
fatty acids, Omega-3
Omega-3-Acid Ethyl Esters

---
https://ansm.sante.fr/actualites/antiepileptiques-et-grossesse-mieux-connaitre-les-risques-pour-lenfant-a-naitre
2023
false
false
false
France
French
technical report
popular works
drug information
anticonvulsants
risk
risk management
abnormalities, drug-induced
pregnancy
abnormalities, drug-induced
child
Neurodevelopmental Disorders

---
https://ansm.sante.fr/actualites/chlorhexidine-attention-au-risque-de-reaction-allergique-immediate-grave
2023
false
false
false
France
French
chlorhexidine
anti-infective agents, local
hypersensitivity, immediate
drug hypersensitivity
pharmacovigilance note

---
https://www.cbip.be/fr/articles/4229?folia=4215
2023
false
false
false
Belgium
French
journal article
Vortioxetine
vortioxetine
administration, oral
antidepressive agents
sexual dysfunctions, psychological
substance withdrawal syndrome

---
https://ansm.sante.fr/tableau-marr/ciltacabtagene-autoleucel
2023
false
false
false
France
French
risk management
guidelines for drug use
patient education handout
Ciltacabtagene Autoleucel
infusions, intravenous
immunotherapy, adoptive
Product containing genetically modified T-cell (product)
Receptors, Chimeric Antigen
Cytokine Release Syndrome
continuity of patient care
Ciltacabtagene Autoleucel
neurotoxicity syndromes
drug compounding
ciltacabtagene autoleucel

---
https://ansm.sante.fr/tableau-marr/rivaroxaban
2023
false
false
false
France
French
Rivaroxaban
risk management
guidelines for drug use
continuity of patient care
administration, oral
medication errors
hemorrhage
Drug-Related side effects and adverse reactions
Rivaroxaban
package leaflet
video recording

---
https://ansm.sante.fr/tableau-marr/apixaban
2023
false
false
false
France
French
guidelines for drug use
risk management
apixaban
administration, oral
apixaban
continuity of patient care
hemorrhage
Drug-Related side effects and adverse reactions
patient education handout

---
https://ansm.sante.fr/tableau-marr/glycopyrronium
2023
false
false
false
France
French
guidelines for drug use
risk management
administration, oral
Glycopyrronium
glycopyrronium
patient education handout
muscarinic antagonists
muscarinic antagonists
Drug-Related side effects and adverse reactions
Drug-Related side effects and adverse reactions
Glycopyrronium
sialorrhea
child
adolescent
chronic disease
nervous system diseases

---
https://www.cbip.be/fr/articles/3988?folia=3979
2023
false
false
false
Belgium
French
pharmacovigilance note
ophthalmic solutions
administration, ophthalmic
risk
prostaglandins, synthetic
pregnancy
abortion, spontaneous
risk assessment

---
https://ansm.sante.fr/tableau-marr/buprenorphine-1
2023
false
false
false
France
French
patients guideline
buprenorphine
risk management
buprenorphine
administration, sublingual
buprenorphine
narcotics
administration, oral

---
https://ansm.sante.fr/actualites/decision-dg-ndeg2023-02-du-13-01-2023-creation-dun-comite-scientifique-temporaire-progestatifs-et-risque-de-meningiome-a-lansm
2023
false
false
false
France
French
drug information
progestins
meningioma
legislation, pharmacy
patient safety

---
PUBLIÉ LE 25/01/2023
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-la-covid-19-periode-du-22-12-2022-au-19-01-2023
2023
false
false
false
France
French
mRNA Vaccine
mRNA Vaccines
NVX-CoV2373 adjuvated lipid nanoparticle
summary of product characteristics
package leaflet
drug information
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
Drug-Related side effects and adverse reactions
drug monitoring
mRNA vaccine
Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 antigen (procedure)
Covid-19 vaccines
COVID-19
COVID-19 Vaccines

---
https://www.cbip.be/fr/articles/3994?folia=3979
2023
false
false
false
Belgium
French
pharmacovigilance note
journal article
stroke
domperidone
metoclopramide
antiemetics
metopimazine
risk assessment

---
https://ansm.sante.fr/actualites/lansm-publie-de-nouvelles-donnees-sur-la-surveillance-des-implants-mammaires
2023
false
false
false
France
French
product surveillance, postmarketing
scientific and technical information
breast implants
france

---
https://ansm.sante.fr/dossiers-thematiques/covid-19-suivi-hebdomadaire-des-cas-deffets-indesirables-des-vaccins
2023
false
false
false
France
French
drug information
COVID-19
COVID-19 Vaccines
vaccination
anaphylaxis
Drug-Related side effects and adverse reactions
Covid-19 vaccines

---
https://ansm.sante.fr/informations-de-securite/codeine-ibuprofene-antarene-codeine-risque-datteintes-renales-gastro-intestinales-et-metaboliques-graves-devolution-parfois-fatale-en-cas-dabus-et-de-dependance-a-lantarene-codeine
https://ansm.sante.fr/actualites/antarene-codeine-codeine-ibuprofene-la-prise-prolongee-en-cas-dabus-et-de-dependance-peut-entrainer-une-toxicite-renale-et-intestinale-pouvant-conduire-au-deces
2023
false
false
false
France
French
pharmacovigilance note
drug combinations
codeine
ibuprofen
codeine and ibuprofen
administration, oral
codeine
opioid-related disorders
intestinal perforation
gastrointestinal hemorrhage
ibuprofen
renal insufficiency
hypokalemia
acidosis, renal tubular
anti-inflammatory agents, non-steroidal
analgesics, opioid

---
https://ansm.sante.fr/actualites/retour-dinformation-sur-le-prac-de-fevrier-2023-6-9-fevrier
2023
false
false
false
France
French
drug information
risk assessment
pseudoephedrine
Posterior reversible encephalopathy syndrome (disorder)
Reversible cerebral vasoconstriction syndrome (disorder)
vasoconstrictor agents
administration, oral

---
PUBLIÉ LE 27/02/2023
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-le-covid-19-periode-du-13-01-2023-au-16-02-2023
2023
false
false
false
France
French
mRNA Vaccine
mRNA Vaccines
NVX-CoV2373 adjuvated lipid nanoparticle
summary of product characteristics
package leaflet
drug information
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
Drug-Related side effects and adverse reactions
drug monitoring
mRNA vaccine
Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 antigen (procedure)
Covid-19 vaccines
COVID-19
COVID-19 Vaccines

---
https://ansm.sante.fr/informations-de-securite/zolgensma-onasemnogene-abeparvovec-cas-dinsuffisance-hepatique-aigue-dissue-fatale
2023
false
false
false
France
French
pharmacovigilance note
risk
onasemnogene abeparvovec-xioi
Onasemnogene Abeparvovec
onasemnogene abeparvovec
liver function tests
continuity of patient care
Monitoring of liver function (regime/therapy)
liver failure, acute
child
infant
liver failure, acute
guidelines for drug use

---
https://www.who.int/fr/news-room/fact-sheets/detail/arsenic
2022
false
Switzerland
French
popular works
arsenic
scientific and technical information
arsenic poisoning
environmental exposure

---
https://presse.inserm.fr/la-consommation-dedulcorants-serait-associee-a-un-risque-accru-de-maladies-cardiovasculaires/45775
2022
false
false
false
France
French
journal article
sweetening agents

---
https://presse.inserm.fr/lazithromycine-apres-une-allogreffe-de-cellules-souches-hematopoietiques-augmenterait-la-rechute-des-hemopathies-malignes/45783
2022
false
false
false
France
French
journal article
azithromycin
hematopoietic stem cell transplantation
recurrence
hematologic neoplasms

---
https://recalls-rappels.canada.ca/fr/avis-rappel/zolgensma-onasemnogene-abeparvovec-et-cas-mortels-insuffisance-hepatique-aigue
2022
false
false
false
Canada
French
English
pharmacovigilance note
liver failure, acute
onasemnogene abeparvovec-xioi
guidelines for drug use
onasemnogene abeparvovec
drug monitoring
continuity of patient care
liver function tests
glucocorticoids
Chemical and Drug Induced Liver Injury
5q spinal muscular atrophy
spinal muscular atrophies of childhood

---
https://ansm.sante.fr/tableau-marr/misoprostol
2022
false
false
false
France
French
risk management
misoprostol
administration, oral
abortion, Drug-Induced
guidelines for drug use
patient education handout
teratogens
continuity of patient care
office visits
abortifacient agents, nonsteroidal
misoprostol

---
https://ansm.sante.fr/tableau-marr/satralizumab
2022
false
false
false
France
French
risk management
satralizumab
drug information
patient education handout
Interleukin Inhibitors
satralizumab
injections, subcutaneous
Infections

---
https://ansm.sante.fr/informations-de-securite/specialites-a-base-dhydroxyethylamidon-hea-v-suspension-des-autorisations-de-mise-sur-le-marche-amm
https://ansm.sante.fr/actualites/suspension-des-autorisations-de-mise-sur-le-marche-amm-des-medicaments-a-base-dhydroxyethylamidon
2022
false
false
false
France
French
pharmacovigilance note
Safety-Based drug withdrawals
hydroxyethyl starch derivatives
hydroxyethylstarch
plasma substitutes
infusions, intravenous
hypovolemia

---
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-le-covid-19-periode-du-2-09-2022-au-29-09-2022
2022
false
false
false
France
French
mRNA Vaccines
2019-nCoV Vaccine mRNA-1273
BNT162 Vaccine
drug information
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
Drug-Related side effects and adverse reactions
drug monitoring
Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 antigen (procedure)
Covid-19 vaccines
COVID-19
COVID-19 Vaccines

---
https://ansm.sante.fr/tableau-marr/tocilizumab
2022
false
false
false
France
French
risk management
guidelines for drug use
patients guideline
continuity of patient care
patient education handout
tocilizumab
tocilizumab
tocilizumab
tocilizumab
injections, subcutaneous
infusions, intravenous
receptors, interleukin-6
interleukin 6 receptor inhibitor
self administration

---
https://ansm.sante.fr/dossiers-thematiques/fluoroquinolones
2022
false
false
false
France
French
fluoroquinolones
fluoroquinolones
guidelines for drug use
risk management
anti-bacterial agents
anti-bacterial agents
fluoroquinolones
Drug-Related side effects and adverse reactions

---
Janus Kinase Inhibitors and the Risk of Major Adverse Cardiovascular Events, Thrombosis (Including Fatal Events) and Malignancy
https://recalls-rappels.canada.ca/fr/avis-rappel/inhibiteurs-janus-kinase-et-risque-manifestation-cardiovasculaire-grave-thrombose-y
2022
false
false
false
Canada
French
English
Janus Kinase Inhibitors
pharmacovigilance note
cardiovascular diseases
thrombosis
neoplasms
abrocitinib
Fedratinib
ruxolitinib
administration, oral
baricitinib
JAK Inhibitor
upadacitinib
tofacitinib
canada

---
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-le-covid-19-periode-du-30-09-2022-au-20-10-2022
2022
false
false
false
France
French
mRNA Vaccines
2019-nCoV Vaccine mRNA-1273
BNT162 Vaccine
menorrhagia
drug information
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
Drug-Related side effects and adverse reactions
drug monitoring
Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 antigen (procedure)
Covid-19 vaccines
COVID-19
COVID-19 Vaccines

---
https://ansm.sante.fr/informations-de-securite/imbruvica-ibrutinib-nouvelles-mesures-de-reduction-des-risques-incluant-des-recommandations-de-modifications-de-dose-en-raison-du-risque-accru-devenements-cardiaques-graves
2022
false
false
false
France
French
pharmacovigilance note
risk management
ibrutinib
ibrutinib
arrhythmias, cardiac
heart failure
ibrutinib
risk factors
continuity of patient care
adult
aged
administration, oral

---
https://ansm.sante.fr/informations-de-securite/acetate-de-chlormadinone-et-acetate-de-nomegestrol-mesures-pour-reduire-le-risque-de-meningiome
https://ansm.sante.fr/actualites/acetate-de-nomegestrol-et-de-chlormadinone-et-meningiome-des-mesures-dans-lensemble-de-leurope-pour-limiter-le-risque
2022
false
false
false
France
French
drug information
meningioma
Drug-Related side effects and adverse reactions
risk management
chlormadinone acetate
nomegestrol acetate

---
https://ansm.sante.fr/informations-de-securite/xalkori-crizotinib-troubles-de-la-vision-incluant-un-risque-de-perte-de-vision-severe-et-necessite-de-surveillance-des-patients-pediatriques
2022
false
false
false
France
French
pharmacovigilance note
Crizotinib
crizotinib
vision disorders
continuity of patient care
blindness
child
risk
vision screening
vision disorders
vision disorders

---
https://ansm.sante.fr/actualites/benfluorex-bilan-du-suivi-des-cas-dhypertension-arterielle-pulmonaire
2022
false
false
false
France
French
drug evaluation
pharmacovigilance
benfluorex
france
hypertension, pulmonary
epidemiological monitoring

---
https://presse.inserm.fr/une-piste-therapeutique-pour-reduire-les-effets-secondaires-dune-chimiotherapie/46005
2022
false
false
false
France
French
journal article
Metabolic Side Effects of Drugs and Substances
antineoplastic agents
cisplatin
istradefylline

---
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-la-covid-19-periode-du-21-10-2022-au-24-11-2022
2022
false
false
false
France
French
mRNA Vaccines
2019-nCoV Vaccine mRNA-1273
BNT162 Vaccine
drug information
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
Drug-Related side effects and adverse reactions
drug monitoring
Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 antigen (procedure)
Covid-19 vaccines
COVID-19
COVID-19 Vaccines

---
https://ansm.sante.fr/actualites/finasteride-1-mg-propecia-et-generiques-ajout-de-mentions-dalerte-sur-les-boites-pour-renforcer-linformation-sur-les-effets-indesirables
2022
false
false
false
France
French
drug information
finasteride
finasteride
patient education handout
alopecia
administration, oral
mental disorders
Reduced libido (finding)
erectile dysfunction
Testicular Pain
Ejaculation Disorder

---
https://ansm.sante.fr/actualites/androcur-acetate-de-cyproterone-les-mesures-prises-depuis-2018-ont-permis-une-nette-reduction-du-risque-de-meningiome
2022
false
false
false
France
French
drug information
cyproterone acetate
meningioma
meningioma
france
administration, oral
cyproterone
product surveillance, postmarketing
pharmacovigilance

---
https://ansm.sante.fr/dossiers-thematiques/androcur-et-risque-de-meningiome
2022
false
false
false
France
French
drug information
cyproterone acetate
meningioma
administration, oral
androgen antagonists
guidelines for drug use
continuity of patient care
product surveillance, postmarketing
Drug-Related side effects and adverse reactions
meningioma
risk management

---
https://www.cbip.be/fr/articles/3962?folia=3941
2022
false
false
false
Belgium
French
journal article
Janus Kinase Inhibitors
tofacitinib

---
https://ansm.sante.fr/informations-de-securite/terlipressine-insuffisance-respiratoire-severe-ou-fatale-et-sepsis-choc-septique-chez-les-patients-atteints-dun-syndrome-hepatorenal-de-type-1-shr-de-type-1
2022
false
false
false
France
French
pharmacovigilance note
Terlipressin
infusions, intravenous
injections, intravenous
terlipressin
respiratory insufficiency
hepatorenal syndrome
Hepatorenal syndrome type 1
shock, septic
sepsis
risk
renal insufficiency
hepatic insufficiency
Terlipressin
continuity of patient care

---
PUBLIÉ LE 27/12/2022
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-la-covid-19-periode-du-25-11-2022-au-22-12-2022
2022
false
false
false
France
French
mRNA Vaccine
mRNA Vaccines
2019-nCoV Vaccine mRNA-1273
BNT162 Vaccine
NVX-CoV2373 adjuvated lipid nanoparticle
drug information
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
Drug-Related side effects and adverse reactions
drug monitoring
mRNA vaccine
Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 antigen (procedure)
Covid-19 vaccines
COVID-19
COVID-19 Vaccines

---
https://www.cbip.be/fr/articles/3752?folia=3740
2022
false
false
false
Belgium
French
journal article
raynaud phenomenon
migraine disorders
erenumab
fremanezumab
galcanezumab
calcitonin gene-related peptide
cohort studies
Calcitonin gene-related peptide (CGRP) antagonists
disease progression

---
Health Canada safety review finds link between the use of Xeljanz and Xeljanz XR (tofacitinib) and increased risk of serious heart-related issues and cancer
https://recalls-rappels.canada.ca/fr/avis-rappel/examen-innocuite-mene-sante-canada-revele-lien-entre-prise-tofacitinib-xeljanz-et
2022
false
false
false
Canada
French
English
risk
tofacitinib
pharmacovigilance note
tofacitinib
risk factors
arthritis, rheumatoid
colitis, ulcerative
tofacitinib
guidelines for drug use
canada
heart diseases
neoplasms
thrombosis
Janus Kinase Inhibitors
Janus Kinase Inhibitors
patient education handout
arthritis, psoriatic
serious infection

---
PAXLOVID (nirmatrelvir and ritonavir) - Dosing and Dispensing in Renal Impairment, Risk of Serious Adverse Reactions Due to Drug Interactions, and English-Only Labels
https://recalls-rappels.canada.ca/fr/avis-rappel/paxlovid-nirmatrelvir-et-ritonavir-posologie-et-administration-en-presence-insuffisance
2022
false
false
false
Canada
French
English
pharmacovigilance note
canada
drug therapy, combination
ritonavir
antiviral agents
lactams
proline
leucine
nitriles
renal insufficiency
drug interactions
COVID-19
adult
administration, oral
Viral Protease Inhibitors
nirmatrelvir and ritonavir
nirmatrelvir and ritonavir drug combination
nirmatrelvir

---
https://ansm.sante.fr/actualites/les-vaccins-a-arnm-contre-la-covid-19-naugmentent-pas-le-risque-dinfarctus-du-myocarde-daccident-vasculaire-cerebral-ou-dembolie-pulmonaire-chez-les-adultes-de-moins-de-75-ans
2022
false
false
false
France
French
drug information
COVID-19
vaccination
mRNA Vaccine
adult
aged
myocardial infarction
pulmonary embolism
stroke
risk
risk assessment
drug monitoring
evaluation studies
summary of product characteristics
package leaflet
ChAdOx1 nCoV-19

---
https://ansm.sante.fr/tableau-marr/naloxone-2
2022
false
false
false
France
French
guidelines for drug use
risk management
naloxone
naloxone
injections, intramuscular
patient education handout
patients guideline
naloxone
emergency treatment
Opiate Overdose
narcotic antagonists
antidotes

---
https://www.has-sante.fr/jcms/p_3309392/fr/flash-securite-patient-calcul-de-doses-medicamenteuses-la-regle-de-trois-doit-rester-la-regle
2022
false
false
false
France
drug dosage calculations
therapeutics
guideline

---
https://ansm.sante.fr/informations-de-securite/acces-compassionnel-a-enfortumab-vedotin-maintien-de-la-suspension-et-recommandations-sur-la-prise-en-charge-des-toxicites-cutanees
2022
false
false
false
France
French
pharmacovigilance note
drug eruptions
stevens-johnson syndrome
epidermal necrolysis, toxic
package leaflet
practice guideline
continuity of patient care
infusions, intravenous
enfortumab vedotin
enfortumab vedotin

---
https://ansm.sante.fr/informations-de-securite/periactine-4-mg-cyproheptadine-risques-lies-a-lutilisation-non-conforme-comme-orexigene-a-des-fins-esthetiques
2022
false
false
false
France
French
administration, oral
Off-Label use
risk
pharmacovigilance note
cyproheptadine
appetite stimulants
weight gain
adult
child

---
https://www.has-sante.fr/jcms/c_2787338/fr/comprendre-les-evenements-indesirables-graves-eigs
2022
false
false
false
France
French
Serious Adverse Event
disclosure
data collection
patient care
legislation, medical
risk
patient safety
technical report
guideline

---
Domperidone and serious ventricular arrhythmias, QT interval prolongation and sudden cardiac death
https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medeffet-canada/infovigilance-produits-sante/janvier-2022.html#domperidone
2022
false
false
false
Canada
French
English
journal article
pharmacovigilance note
domperidone

---
https://ansm.sante.fr/informations-de-securite/tegeline-50-mg-ml-immunoglobuline-humaine-normale-iv-poudre-et-solvant-pour-solution-pour-perfusion-information-sur-le-risque-dinsuffisance-renale
2022
false
false
false
France
French
infusions, intravenous
pharmacovigilance note
risk
immunoglobulins, intravenous
immunologic factors
acute kidney injury
renal insufficiency, acute
guidelines for drug use
risk factors
immunoglobulins, normal human, for intravascular adm.
continuity of patient care
drug monitoring
sucrose

---
https://www.cochrane.org/fr/CD015308/EMERG_les-medicaments-qui-bloquent-linterleukine-1-une-proteine-impliquee-dans-les-reponses-immunitaires
2022
false
false
false
United Kingdom
interleukin 1 receptor antagonist protein
interleukin 1 receptor antagonist protein
review of literature
french abstract
COVID-19

---
https://www.epi-phare.fr/
2022
false
false
false
France
French
pharmacoepidemiology
france
databases, factual
pharmaceutical preparations
establishment, institution, organization
epidemiologic studies
references
epidemiological monitoring

---
BEOVU (brolucizumab) – Risk of Intraocular Inflammation, Retinal Vasculitis and/or Retinal Vascular Occlusion
https://recalls-rappels.canada.ca/fr/avis-rappel/beovu-brolucizumab-risque-inflammation-intraoculaire-vascularite-retinienne-etou
2022
false
false
false
Canada
French
English
pharmacovigilance note
brolucizumab
intravitreal injections
Product containing only brolucizumab in parenteral dose form (medicinal product form)
canada
wet macular degeneration
brolucizumab
retinal vasculitis
Retinal Vascular Occlusion

---
https://www.cbip.be/fr/articles/3759?folia=3757
2022
false
false
false
Belgium
French
journal article
administration, oral
cholinergic antagonists
eye diseases
diphosphonates
amiodarone
hydroxychloroquine
phenothiazines
glucocorticoids

---
https://www.cbip.be/fr/articles/3762?folia=3757
2022
false
false
false
Belgium
French
journal article
quinolones
anti-bacterial agents
quinolone antibacterials

---
https://ansm.sante.fr/tableau-marr/acide-zoledronique
2022
false
false
false
France
French
risk management
patients guideline
guidelines for drug use
Zoledronic Acid
Drug-Related side effects and adverse reactions
bone density conservation agents
Bisphosphonate-Associated osteonecrosis of the jaw
risk
zoledronic acid

---
https://www.cochrane.org/fr/CD013320/VASC_un-taux-de-sucre-faible-pour-prevenir-les-maladies-cardiovasculaires
2022
false
false
false
United Kingdom
Heart Disease Risk Factors
review of literature
french abstract
Sugars
cardiovascular diseases

---
https://www.cochrane.org/fr/CD013790/TOBACCO_les-produits-du-tabac-chauffes-aident-ils-les-gens-arreter-de-fumer-sont-ils-surs-et-ont-ils
2022
false
false
false
United Kingdom
Heated Tobacco Product
smoking cessation
review of literature
french abstract
tobacco products

---
https://www.cochrane.org/fr/CD013167/BREASTCA_therapies-systemiques-dans-la-prevention-ou-le-traitement-des-symptomes-musculo-squelettiques
2022
false
false
false
United Kingdom
Early Stage Breast Carcinoma
signs and symptoms
Systemic Therapy
musculoskeletal pain
musculoskeletal pain
aromatase inhibitors
review of literature
french abstract
aromatase inhibitors
neoplasm staging
breast neoplasms

---
https://ansm.sante.fr/informations-de-securite/mavenclad-10-mg-comprimes-cladribine-risque-datteintes-hepatiques-graves-et-nouvelles-recommandations-sur-le-controle-de-la-fonction-hepatique
2022
false
false
false
France
French
pharmacovigilance note
guidelines for drug use
continuity of patient care
administration, oral
cladribine
cladribine
Chemical and Drug Induced Liver Injury
cladribine
liver function tests

---
PUBLIÉ LE 18/02/2022
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-la-covid-19-periode-du-28-01-2022-au-10-02-2022
2022
false
false
false
France
French
mRNA Vaccine
mRNA Vaccines
2019-nCoV Vaccine mRNA-1273
BNT162 Vaccine
drug information
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
Drug-Related side effects and adverse reactions
drug monitoring
mRNA vaccine
Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 antigen (procedure)
Covid-19 vaccines
COVID-19
COVID-19 Vaccines

---
Nous contacter.
19/04/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.